High baseline serum levels of VEGF, high initial sICAM-1 and sE-selectin, and significant increase in PAI-1 levels are prognostics for poorer prognosis in a short-term observation in children treated for ALL. This evidence concerns the gene VEGFA and acute lymphoblastic leukemia.